{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:16:28Z","timestamp":1790622988385,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_I","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Early coronary revascularization is a first choice therapeutic strategy in the case of acute myocardial infarction (MI). Despite an early coronary angioplasty, however, in some cases, there is a lower efficacy of revascularization, with less favourable clinical outcome in the short and long terms. Various elements participate in the distant prognosis after primary coronary angioplasty (PCI). Among the clinical risk factors that predispose to a recurrence of ischaemic cardiovascular events are advanced age, diabetes mellitus, chronic renal failure, peripheral vascular disease, atrial fibrillation and the multiplicity of cardiovascular risk factors, which identify a higher baseline risk profile. The risk factors associated with the percutaneous interventional procedure include the presence of diffuse or complex coronary lesions, the use of small diameter stents or a suboptimal post procedural thrombolysis in MI flow. The occurrence of procedural complications, such as no-reflow, is in fact associated with an increase in the infarct area and a worse prognosis, as it favours negative ventricular remodelling. The presence of concomitant right ventricular dysfunction, the high ventricular arrhythmic burden in the acute phase, the presence of risk factors for thrombosis or intra-stent restenosis also affect the outcome after primary PCI.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suac102","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T15:19:18Z","timestamp":1668266358000},"page":"I114-I118","source":"Crossref","is-referenced-by-count":4,"title":["Why can primary angioplastics be ineffective despite the precocity of the intervention?"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-3968","authenticated-orcid":false,"given":"Giuseppe","family":"Patti","sequence":"first","affiliation":[{"name":"University of Eastern Piedmont Amedeo Avogadro"},{"name":"Maggiore della Carit\u00e0 Hospital , Novara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ghiglieno","sequence":"additional","affiliation":[{"name":"University of Eastern Piedmont Amedeo Avogadro"},{"name":"Maggiore della Carit\u00e0 Hospital , Novara"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"2022111417524806600_suac102-B1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.carrev.2019.11.009","article-title":"Relation of frailty to outcomes in percutaneous coronary intervention","volume":"21","author":"Kwok","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"2022111417524806600_suac102-B2","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jacc.2012.08.993","article-title":"Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry 2004 to 2008","volume":"60","author":"Hillegass","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022111417524806600_suac102-B3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022111417524806600_suac102-B4","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/jcm10194574","article-title":"Risk stratification of patients with acute coronary syndrome","volume":"10","author":"Bauer","year":"2021","journal-title":"J Clin Med"},{"key":"2022111417524806600_suac102-B5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006955","article-title":"Impact of atrial fibrillation during ST-segment-elevation myocardial infarction on infarct characteristics and prognosis","volume":"11","author":"Reinstadler","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022111417524806600_suac102-B6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2022111417524806600_suac102-B7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.116.022061","article-title":"Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention","volume":"134","author":"Kirtane","year":"2016","journal-title":"Circulation"},{"key":"2022111417524806600_suac102-B8","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1093\/eurheartj\/ehy562","article-title":"Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial","volume":"39","author":"Stone","year":"2018","journal-title":"Eur Heart J"},{"key":"2022111417524806600_suac102-B9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00059-018-4723-1","article-title":"Predictors of angiographically visible distal embolization in STEMI","volume":"45","author":"Yam\u00e9ogo","year":"2020","journal-title":"Herz"},{"key":"2022111417524806600_suac102-B10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022111417524806600_suac102-B11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00019501-200602000-00012","article-title":"Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: report from the New York State Angioplasty Registry","volume":"17","author":"Kong","year":"2006","journal-title":"Coron Artery Dis"},{"key":"2022111417524806600_suac102-B12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCIMAGING.109.914366","article-title":"Prognostic value of right ventricular function in patients after acute myocardial infarction treated with primary percutaneous coronary intervention","volume":"3","author":"Antoni","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022111417524806600_suac102-B13","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1215802","article-title":"Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers","volume":"2020","author":"Berezin","year":"2020","journal-title":"Dis Markers"},{"key":"2022111417524806600_suac102-B14","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur Heart J"},{"key":"2022111417524806600_suac102-B15","first-page":"637","article-title":"Coronary in-stent restenosis: predictors and treatment","volume":"118","author":"Ullrich","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"2022111417524806600_suac102-B16","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.amjcard.2017.07.080","article-title":"Early ventricular tachycardia or fibrillation in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention and impact on mortality and stent thrombosis (from the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial)","volume":"120","author":"Kosmidou","year":"2017","journal-title":"Am J Cardiol"},{"key":"2022111417524806600_suac102-B17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.CIR.0000022692.49934.E3","article-title":"Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes","volume":"106","author":"Al-Khatib","year":"2002","journal-title":"Circulation"},{"key":"2022111417524806600_suac102-B18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijcard.2014.08.055","article-title":"Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study","volume":"176","author":"Doi","year":"2014","journal-title":"Int J Cardiol"},{"key":"2022111417524806600_suac102-B19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"2022111417524806600_suac102-B20","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"2022111417524806600_suac102-B21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2016.05.049","article-title":"Predicting in-hospital mortality in patients with acute myocardial infarction","volume":"68","author":"McNamara","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_I\/I114\/47030504\/suac102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_I\/I114\/47030504\/suac102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:56:55Z","timestamp":1668448615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/24\/Supplement_I\/I114\/6823851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":21,"journal-issue":{"issue":"Supplement_I","published-online":{"date-parts":[[2022,11,12]]},"published-print":{"date-parts":[[2022,11,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac102","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,12]]},"published":{"date-parts":[[2022,11,12]]}}}